Table 3a.
Significantly affected genes within TGF-β/BMP signaling pathway.
| Gene title | Gene symbol | p-Value | Fold-change (S vs. C)a |
|---|---|---|---|
| bone morphogenetic protein 1 | BMP1 | 0.04 | − 1.33 |
| bone morphogenetic protein receptor, type IA | BMPR1A | 0.04 | 1.19 |
| bone morphogenetic protein 5 | BMP5 | 0.04 | 1.16 |
| bone morphogenetic protein 7 | BMP7 | 0.03 | 1.21 |
| caveolin 1, caveolae protein, 22 kDa | CAV1 | 0.03 | 1.54 |
| CREB-binding protein | CBP | 0.01 | 1.31 |
| growth arrest and DNA-damage-inducible, beta | GADD45B | 0.03 | 1.30 |
| mitogen-activated protein kinase kinase 6 | MEK6 | 0.04 | − 1.14 |
| ribosomal protein S6 kinase, 90kDa, polypeptide 5 | RPS6KA5 | 0.01 | 1.11 |
| SHC (Src homology 2 domain containing)-transforming protein 1 | SHC1 | 0.03 | 1.16 |
| SMAD family member 4 | SMAD4 | 0.01 | 1.19 |
| SMAD family member 5 | SMAD5 | 0.02 | 1.48 |
| SKI-like oncogene | SKIL | 0.02 | − 1.15 |
| transcription factor specificity protein 1 | SP1 | 0.03 | 1.29 |
| X-linked inhibitor of apoptosis | XIAP | 0.02 | 1.10 |
| zinc finger, FYVE domain containing 9 | ZFYVE9/SARA | 0.04 | 1.14 |
S = schizophrenia; C = control.